More Investing
View Older Stories View Newer Stories-
Corebridge and Equitable to merge in $22 billion all-stock deal
-
Pony AI rises nearly 3% on earnings beat, robotaxi revenue surge, UBER Partnership
-
Futures dip, oil tops $100 as Iran reviews U.S. peace plan - what’s moving markets
-
Hensoldt AG FY25 net profit drops 18% as tax bill triples despite record orders
-
General Dynamics unit wins $95 million Navy submarine contract
-
Binance tightens rules for token issuers and market makers
-
Iran warns of strikes on regional ally if "island" occupation attempted
-
Trump and Xi to hold Beijing summit in May after postponement
-
Trump ready to hit Iran harder if Tehran fails to accept defeat, says White House
-
Raymond James: Volatility continues to cloud Big Oil outlook
-
Venezuela oil output climbs to 1.1 million bpd in March
-
Denali shares jump on FDA approval of Hunter syndrome drug
-
U.S. stock valuations point to near-term upside, Citadel strategist says
-
Generac stock tumbles as data center deal hopes disappoint
-
Why you should buy the Google-related pullback in memory stocks
-
GM upgraded at Wolfe Research as firm sees ‘select opportunities’ in autos
-
U.S. space stocks soar on accelerated SpaceX IPO
-
Iran rejects U.S. 15-point peace plan, vows to continue operations
-
SIX Group CEO sees better year for European IPOs despite Iran war
-
Why markets haven't seen a 2022-style shock yet
-
MU, WDC, SNDK fall: Why Google's TurboQuant is rattling memory stocks
-
Bernstein sees 1970s-style supercycle for Middle East oil services
-
Paychex beats estimates as Paycor acquisition boosts growth
-
Bunge shares trade lower as short seller calls for independent investigation
-
Russia says U.S.-South Korea drills are open preparation for war
-
Cintas rises after lifting full-year outlook; FQ3 meets estimates
-
Iran rejects US ceasefire proposal, calls talks illogical
-
Only 22% of global workers believe their jobs are safe, ADP finds
-
Intel stock jumps on report of CPU price hikes
-
UBS sees limited macro strain from $100 oil vs. 1974 levels
-
Enliven Therapeutics stock surges 28% on Merck-Terns deal
-
Chewy shares surge on fourth quarter earnings beat
-
Equity positioning nowhere near capitulation levels: Barclays
-
Nanobiotix stock jumps on takeover report involving J&J
-
Codere mulls potential $2.3 billion sale, Expansion says
-
Temu owner PDD misses earnings, revenue forecasts in Q4
-
Merck to buy oncology firm Terns Pharmaceuticals in $6.7 billion deal
-
Arm shares rally as analysts cheer new AGI chip
-
Space stocks gain premarket Wednesday on accelerated SpaceX IPO
-
UPS opens $100 million logistics center in Taiwan amid tech demand
-
China food-delivery stocks jump as regulators move to curb price wars
-
Witkoff and Kushner working on one-month Iran ceasefire mechanism, report says
-
Trump says Iran gave ’present’ amid ongoing talks
-
JPMorgan’s Dimon: Iran war risky near-term, but may bring Middle East peace
-
ADMA Biologics shares plunge on short seller allegations
-
Prediction markets show low odds for Hormuz Strait reopening soon
-
Software is sick again today... and it's not just because of Claude
-
ARM gains on plan to sell own chips for first time in push for AI revenue
-
Travel demand holding up well despite Middle East conflict - analyst
-
UAE oil chief calls Iran attacks "economic terrorism against every nation"
